98 related articles for article (PubMed ID: 1775133)
1. Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s).
Muller M; Baniahmad C; Kaltschmidt C; Renkawitz R
Mol Endocrinol; 1991 Oct; 5(10):1498-503. PubMed ID: 1775133
[TBL] [Abstract][Full Text] [Related]
2. Co-operative binding of the glucocorticoid receptor DNA binding domain is one of at least two mechanisms for synergism.
Baniahmad C; Muller M; Altschmied J; Renkawitz R
J Mol Biol; 1991 Nov; 222(2):155-65. PubMed ID: 1960719
[TBL] [Abstract][Full Text] [Related]
3. High level expression of the major transactivation domain of the human glucocorticoid receptor in yeast cells inhibits endogenous gene expression and cell growth.
Wright AP; McEwan IJ; Dahlman-Wright K; Gustafsson JA
Mol Endocrinol; 1991 Oct; 5(10):1366-72. PubMed ID: 1775128
[TBL] [Abstract][Full Text] [Related]
4. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors.
Rowlands JC; McEwan IJ; Gustafsson JA
Mol Pharmacol; 1996 Sep; 50(3):538-48. PubMed ID: 8794892
[TBL] [Abstract][Full Text] [Related]
5. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
Seipel K; Georgiev O; Gerber HP; Schaffner W
Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
[TBL] [Abstract][Full Text] [Related]
6. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain.
Folkers GE; van der Leede BJ; van der Saag PT
Mol Endocrinol; 1993 Apr; 7(4):616-27. PubMed ID: 8389001
[TBL] [Abstract][Full Text] [Related]
7. A thyroid hormone receptor-dependent glucocorticoid induction.
Leers J; Steiner C; Renkawitz R; Muller M
Mol Endocrinol; 1994 Apr; 8(4):440-7. PubMed ID: 8052265
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene.
Rennie PS; Bruchovsky N; Leco KJ; Sheppard PC; McQueen SA; Cheng H; Snoek R; Hamel A; Bock ME; MacDonald BS
Mol Endocrinol; 1993 Jan; 7(1):23-36. PubMed ID: 8446105
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.
Goswami R; Lacson R; Yang E; Sam R; Unterman T
Endocrinology; 1994 Feb; 134(2):736-43. PubMed ID: 7507835
[TBL] [Abstract][Full Text] [Related]
10. Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor.
Schüle R; Muller M; Otsuka-Murakami H; Renkawitz R
Nature; 1988 Mar; 332(6159):87-90. PubMed ID: 2831456
[TBL] [Abstract][Full Text] [Related]
11. Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor tau 1-core activation domain and target factors.
Almlöf T; Wallberg AE; Gustafsson JA; Wright AP
Biochemistry; 1998 Jun; 37(26):9586-94. PubMed ID: 9649342
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.
Fujii M; Tsuchiya H; Seiki M
Oncogene; 1991 Dec; 6(12):2349-52. PubMed ID: 1766679
[TBL] [Abstract][Full Text] [Related]
13. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors.
Liu M; Freedman LP
Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding.
Lechner J; Welte T; Doppler W
Immunobiology; 1997 Dec; 198(1-3):112-23. PubMed ID: 9442383
[TBL] [Abstract][Full Text] [Related]
16. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
Ghosh S; Selby MJ; Peterlin BM
J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
[TBL] [Abstract][Full Text] [Related]
17. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
Connor LM; Oxman MN; Brady JN; Marriott SJ
Virology; 1993 Aug; 195(2):569-77. PubMed ID: 8337832
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of chromatin remodelling factors during gene activation via the glucocorticoid receptor N-terminal domain.
Wallberg AE; Flinn EM; Gustafsson JA; Wright AP
Biochem Soc Trans; 2000; 28(4):410-4. PubMed ID: 10961930
[TBL] [Abstract][Full Text] [Related]
19. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
Shim YH; Bonner JJ; Blumenthal T
J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface.
Liu W; Wang J; Yu G; Pearce D
Mol Endocrinol; 1996 Nov; 10(11):1399-406. PubMed ID: 8923466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
